How High Can Crowdstrike Stock Go?

Wall Street pays a premium for fast growth companies and Crowdstrike (NASDAQ:CRWD) fits squarely into that category with revenues climbing by 39.9% over the Market News [Financhill] Smart Trading. Simplified. [This $20 AI Company Could Be the Next Microsoft](~/AACAmgA~/RgRnh9yTP0R9aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02ODMmYWQ9YUhSMGNITTZMeTkzZDNjdWFXMXphbXByTXpBNUxtTnZiUzh5VkVOWVVERXpMelZUUWxCVVJsY3ZQMk55WldGMGFYWmxYMmxrUFRJM01qRT1XA3NwY0IKZaLiV6VlGxMJIlIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAA) Ready for the artificial intelligence megaboom? Uncover the AI stocks set to soar. These trillion-dollar companies of tomorrow are trading for pennies today. [Discover My #1 AI Stock](~/AACAmgA~/RgRnh9yTP0R9aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02ODMmYWQ9YUhSMGNITTZMeTkzZDNjdWFXMXphbXByTXpBNUxtTnZiUzh5VkVOWVVERXpMelZUUWxCVVJsY3ZQMk55WldGMGFYWmxYMmxrUFRJM01qRT1XA3NwY0IKZaLiV6VlGxMJIlIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAA) Sponsored [How High Can Crowdstrike Stock Go?](~/AACAmgA~/RgRnh9yTP0RMaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9uZXh0L2Jsb2cvaW52ZXN0aW5nL2hvdy1oaWdoLWNhbi1jcm93ZHN0cmlrZS1zdG9jay1nb1cDc3BjQgplouJXpWUbEwkiUht0cmlzdHJhbWJhbGR3aW44OUBnbWFpbC5jb21YBAAAAAA~) Wall Street pays a premium for fast growth companies and Crowdstrike (NASDAQ:CRWD) fits squarely into that category with revenues climbing by 39.9% over the past year. That’s likely one of the reasons why Blue Zone Wealth Advisors with $288.5 million in assets under management took a stake in the firm. The last few years have […] [Continue Reading >](~/AACAmgA~/RgRnh9yTP0RMaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9uZXh0L2Jsb2cvaW52ZXN0aW5nL2hvdy1oaWdoLWNhbi1jcm93ZHN0cmlrZS1zdG9jay1nb1cDc3BjQgplouJXpWUbEwkiUht0cmlzdHJhbWJhbGR3aW44OUBnbWFpbC5jb21YBAAAAAA~) Check out the Seasonal Trend for THC [View Seasonality for THC](~/AACAmgA~/RgRnh9yTP0R1aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9zZWFzb25hbGl0eS9jaGFydHMvVEhDP3V0bV9tZWRpdW09ZW1haWwmdXRtX3NvdXJjZT1CbG9nRGlnZXN0JnV0bV9jYW1wYWlnbj0yMDI0MDExNV9uZXdzbGV0dGVyVwNzcGNCCmWi4lelZRsTCSJSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAA~~) [Boost Your Portfolio with This Ultra Low-Priced Uranium Stock](~/AACAmgA~/RgRnh9yTP0R9aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02OTEmYWQ9YUhSMGNITTZMeTkzZDNjdWFXMXphbXByTXpBNUxtTnZiUzh5VkVOWVVERXpMelZYU0ZOUVUwd3ZQMk55WldGMGFYWmxYMmxrUFRJM056RT1XA3NwY0IKZaLiV6VlGxMJIlIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAA) Small-cap uranium stocks are booming as the world turns to clean-burning nuclear energy fueled by uranium. This ultra low-priced uranium stock - trading around US$0.30 - is advancing a rare high-grade discovery in the #1 uranium district in the world. [Check out our free report here.](~/AACAmgA~/RgRnh9yTP0R9aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02OTEmYWQ9YUhSMGNITTZMeTkzZDNjdWFXMXphbXByTXpBNUxtTnZiUzh5VkVOWVVERXpMelZYU0ZOUVUwd3ZQMk55WldGMGFYWmxYMmxrUFRJM056RT1XA3NwY0IKZaLiV6VlGxMJIlIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAA) Sponsored [Activist Investor Bets Big On Healthcare Firm](~/AACAmgA~/RgRnh9yTP0RUaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy93aHktZGlkLWVsbGlvdHQtbWFuYWdlbWVudC1idXktY2FyZGluYWwtaGVhbHRoVwNzcGNCCmWi4lelZRsTCSJSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAA~~) Activist investor Elliott Management may only have allotted 2.3% of its portfolio to Cardinal Health (NYSE:CAH) but with $13.9 billion in assets under management that still amounts to a large investment. What is it about this healthcare firm that the investment team at Elliott have spotted to give them so much conviction as to take […] [Continue Reading >](~/AACAmgA~/RgRnh9yTP0RUaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy93aHktZGlkLWVsbGlvdHQtbWFuYWdlbWVudC1idXktY2FyZGluYWwtaGVhbHRoVwNzcGNCCmWi4lelZRsTCSJSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAA~~) [Early Profit-Advantage on 30-cent Uranium Stock as Prices Soar](~/AACAmgA~/RgRnh9yTP0R9aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02OTAmYWQ9YUhSMGNITTZMeTkzZDNjdWFXMXphbXByTXpBNUxtTnZiUzh5VkVOWVVERXpMelZYUjBaVU5ERXZQMk55WldGMGFYWmxYMmxrUFRJM056QT1XA3NwY0IKZaLiV6VlGxMJIlIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAA) Investors are lining up for gains in the New Uranium Bull Market. One tiny Canadian uranium company - currently trading undiscovered by Wall Street around US$0.30 per share - has confirmed a near-surface, high-grade uranium discovery in the hotbed of global uranium production. Next drill results, due any day now, could send this 30-cent stock skyward. Do not miss this timely profit opportunity. [Learn more here.](~/AACAmgA~/RgRnh9yTP0R9aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02OTAmYWQ9YUhSMGNITTZMeTkzZDNjdWFXMXphbXByTXpBNUxtTnZiUzh5VkVOWVVERXpMelZYUjBaVU5ERXZQMk55WldGMGFYWmxYMmxrUFRJM056QT1XA3NwY0IKZaLiV6VlGxMJIlIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAA) Sponsored [1 Investment Manager Went All In On Soda Firm](~/AACAmgA~/RgRnh9yTP0REaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9pcy1kci1wZXBwZXItc3RvY2stdW5kZXJ2YWx1ZWRXA3NwY0IKZaLiV6VlGxMJIlIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAA) When an investment manager with $190 million in assets under management deploys 69.7% of their portfolio to a single stock, it’s worth perking up and taking notice. That’s exactly what Lexington Partners has done by allocating a huge portion of their fund to Keurig Dr Pepper (NASDAQ:KDP) which invites the question what is it about […] [Continue Reading >](~/AACAmgA~/RgRnh9yTP0REaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9pcy1kci1wZXBwZXItc3RvY2stdW5kZXJ2YWx1ZWRXA3NwY0IKZaLiV6VlGxMJIlIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAA) [It Doesn't Matter if You've Got $500 or $5 Million to Invest...](~/AACAmgA~/RgRnh9yTP0R9aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02ODAmYWQ9YUhSMGNITTZMeTkzZDNjdWFXMXphbXByTXpBNUxtTnZiUzh5VkVOWVVERXpMelZUTlRaQ1NFY3ZQMk55WldGMGFYWmxYMmxrUFRJM01UZz1XA3NwY0IKZaLiV6VlGxMJIlIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAA) Warning: A "Black Swan" event is poised to blindside millions of Americans. Millions of high-paying, white-collar jobs will be lost. Dozens of businesses will go bankrupt. You need to prepare your finances now. It doesn't matter if you've got $500 or $5 million. [Click here for a first-hand look.](~/AACAmgA~/RgRnh9yTP0R9aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02ODAmYWQ9YUhSMGNITTZMeTkzZDNjdWFXMXphbXByTXpBNUxtTnZiUzh5VkVOWVVERXpMelZUTlRaQ1NFY3ZQMk55WldGMGFYWmxYMmxrUFRJM01UZz1XA3NwY0IKZaLiV6VlGxMJIlIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAA) Sponsored [Is it Too Late to Buy LLY Stock?](~/AACAmgA~/RgRnh9yTP0RFaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9pcy1pdC10b28tbGF0ZS10by1idXktbGx5LXN0b2NrVwNzcGNCCmWi4lelZRsTCSJSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAA~~) Eli Lilly (NYSE:LLY) has been on an impressive run lately. The pharmaceutical stock has gained 77% in the last year and achieved record highs of over $635 per share. Investors who bought shares of LLY early on have clearly done well, but is it too late for new shareholders to get in on Eli Lilly’s growth? […] [Continue Reading >](~/AACAmgA~/RgRnh9yTP0RFaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9pcy1pdC10b28tbGF0ZS10by1idXktbGx5LXN0b2NrVwNzcGNCCmWi4lelZRsTCSJSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAA~~) [Wall Streets "King of Quants" Warns: "We've Created a Monster"](~/AACAmgA~/RgRnh9yTP0R9aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02ODEmYWQ9YUhSMGNITTZMeTkzZDNjdWFXMXphbXByTXpBNUxtTnZiUzh5VkVOWVVERXpMelZUTmtzM09ETXZQMk55WldGMGFYWmxYMmxrUFRJM01Uaz1XA3NwY0IKZaLiV6VlGxMJIlIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAA) One of the world's top investors has issued a dire warning... A.I. will eat jobs, destroy businesses and crush stock portfolios starting around January 2024. It doesn't matter if you have $500 or $5 million... [You need to make these threecritical moves right now... or risk losing everything](~/AACAmgA~/RgRnh9yTP0R9aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02ODEmYWQ9YUhSMGNITTZMeTkzZDNjdWFXMXphbXByTXpBNUxtTnZiUzh5VkVOWVVERXpMelZUTmtzM09ETXZQMk55WldGMGFYWmxYMmxrUFRJM01Uaz1XA3NwY0IKZaLiV6VlGxMJIlIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAA) Sponsored [Analysts Forecast Big Gain For Auto Stock](~/AACAmgA~/RgRnh9yTP0Q_aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9ib3Jnd2FybmVyLXN0b2NrLWZvcmVjYXN0VwNzcGNCCmWi4lelZRsTCSJSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAA~~) In Boca Raton, Florida an investment manager with the highly unusual name of Iii Capital Management manages $1.5 billion and has taken a meaningful stake in BorgWarner (NYSE:BWA), an automotive supplier. A peek under the hood reveals what the money manager has uncovered that may pique investors’ interests too. BorgWarner vs S&P 500 Over the […] [Continue Reading >](~/AACAmgA~/RgRnh9yTP0Q_aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9ib3Jnd2FybmVyLXN0b2NrLWZvcmVjYXN0VwNzcGNCCmWi4lelZRsTCSJSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAA~~) [Groundbreaking AI Drug Development - Stock Alert!](~/AACAmgA~/RgRnh9yTP0R9aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02ODcmYWQ9YUhSMGNITTZMeTkzZDNjdWFXMXphbXByTXpBNUxtTnZiUzh5VkVOWVVERXpMelZYTkZCTldGRXZQMk55WldGMGFYWmxYMmxrUFRJM05qRT1XA3NwY0IKZaLiV6VlGxMJIlIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAA) Be part of a healthcare revolution! This innovative company is leading the charge in AI-driven drug development, working with global pharma giants. Priced under $10, this stock is swiftly attracting Wall Street's interest. Grab your chance to learn more about this incredible opportunity. [Watch our exclusive breakdown](~/AACAmgA~/RgRnh9yTP0R9aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02ODcmYWQ9YUhSMGNITTZMeTkzZDNjdWFXMXphbXByTXpBNUxtTnZiUzh5VkVOWVVERXpMelZYTkZCTldGRXZQMk55WldGMGFYWmxYMmxrUFRJM05qRT1XA3NwY0IKZaLiV6VlGxMJIlIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAA) Sponsored View this email [online](~/AACAmgA~/RgRnh9yTP0QbaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nVwNzcGNCCmWi4lelZRsTCSJSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAA~~) if it doesn't display correctly. This newsletter is not financial advice. Please read our [Disclaimer](~/AACAmgA~/RgRnh9yTP0QcaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS90ZXJtc1cDc3BjQgplouJXpWUbEwkiUht0cmlzdHJhbWJhbGR3aW44OUBnbWFpbC5jb21YBAAAAAA~). To unsubscribe from Financhill, [click here](~/AACAmgA~/RgRnh9yTP0RSaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS91bnN1YnNjcmliZS83MTExOGRiZTAwOTkxYmE1MzA4MjIyZDU3NjA3ZWMxNC01NDgyODQxNS04NjkxNFcDc3BjQgplouJXpWUbEwkiUht0cmlzdHJhbWJhbGR3aW44OUBnbWFpbC5jb21YBAAAAAA~). PO Box 126 Catasauqua, PA 18032 Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory. The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email. The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: [Characteristics and Risks of Standardized Options](~/AACAmgA~/RgRnh9yTP0RFaHR0cDovL3d3dy5vcHRpb25zY2xlYXJpbmcuY29tL2Fib3V0L3B1YmxpY2F0aW9ucy9jaGFyYWN0ZXItcmlza3MuanNwVwNzcGNCCmWi4lelZRsTCSJSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAA~~). The Financhill.com educational training program and software services are provided to improve financial understanding. The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing. Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.